Related Experiment Videos
Periosteal reaction induced by prostaglandins
J G Niethammer1, K A Rule, V Lorch
1Department of Radiology, University of Tennessee Medical Center, Knoxville 37920.
American Journal of Perinatology
|July 1, 1992
Summary
Prostaglandin E1 therapy for ductal-dependent congenital heart disease can cause a rare side effect. A case of tetralogy of Fallot with Noonan syndrome experienced a diffuse periosteal reaction after two months of treatment.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Medical Case Reports
Background:
- Prostaglandin administration is a critical intervention for ductal-dependent congenital heart disease.
- Early diagnosis and management are essential for improving outcomes in complex pediatric cardiac conditions.
Observation:
- A case involving tetralogy of Fallot and Noonan syndrome presented with small pulmonary arteries, necessitating a delay in surgical intervention.
- Intravenous prostaglandin E1 was administered for two months to maintain ductal patency.
Findings:
- A diffuse periosteal reaction was observed as an adverse effect of prolonged intravenous prostaglandin E1 administration.
- This finding highlights a potential, albeit rare, complication associated with prostaglandin therapy in neonates.
Implications:
- Clinicians should be vigilant for unusual side effects, such as periosteal reactions, during extended prostaglandin therapy for congenital heart disease.
- This case underscores the importance of careful monitoring and risk-benefit assessment in managing complex pediatric cardiac conditions.